Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioMarin Pharmaceutical Inc. - Common Stock
(NQ:
BMRN
)
60.07
-1.07 (-1.75%)
Streaming Delayed Price
Updated: 11:58 AM EST, Dec 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
503,697
Open
61.24
Bid (Size)
60.05 (400)
Ask (Size)
60.10 (600)
Prev. Close
61.14
Today's Range
59.81 - 61.24
52wk Range
50.76 - 73.51
Shares Outstanding
183,352,255
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Clearwater Analytics Holdings, Inc. (NYSE - CWAN), Katapult Holdings, Inc. (Nasdaq - KPLT), Janus Henderson Group plc (NYSE - JHG), Amicus Therapeutics, Inc. (Nasdaq
December 23, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know
December 23, 2025
Shares of biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) jumped 2.6% in the afternoon session after the stock's positive momentum continued as the company agreed to acquire Amicus Therapeutics...
Via
StockStory
Performance
YTD
-9.7%
-9.7%
1 Month
+8.2%
+8.2%
3 Month
+12.5%
+12.5%
6 Month
+9.8%
+9.8%
1 Year
-9.4%
-9.4%
More News
Read More
Amicus Stock Surges To Near 2-Year Highs On BioMarin's $4.8B Buyout Deal
↗
December 19, 2025
Via
Stocktwits
Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today
December 19, 2025
Via
StockStory
Topics
Economy
Which stocks are gapping on Friday?
↗
December 19, 2025
Via
Chartmill
1 Oversold Stock Primed to Rebound and 2 That Underwhelm
December 15, 2025
Via
StockStory
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Presents a Compelling Value Investment Case
↗
December 08, 2025
Via
Chartmill
Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms
↗
December 03, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million?
↗
December 03, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Dyne Therapeutics Stock Down 30% in a Year — So Why Did One Investor Add Nearly 1 Million Shares?
↗
December 03, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
December 03, 2025
Via
MarketMinute
2 Reasons to Like BMRN and 1 to Stay Skeptical
November 24, 2025
Via
StockStory
Topics
Stocks
Q3 Earnings Outperformers: BioMarin Pharmaceutical (NASDAQ:BMRN) And The Rest Of The Therapeutics Stocks
November 23, 2025
Via
StockStory
Topics
Artificial Intelligence
AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know
November 21, 2025
Via
StockStory
Topics
Economy
Government
World Trade
BioMarin Pharmaceutical (BMRN): Buy, Sell, or Hold Post Q3 Earnings?
November 20, 2025
Via
StockStory
Topics
Stocks
Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know.
↗
November 20, 2025
Via
The Motley Fool
The Tech Tsunami: How Breakthroughs in AI, Quantum, and Green Energy Are Reshaping the Stock Market
November 14, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
1 Safe-and-Steady Stock on Our Watchlist and 2 We Question
November 12, 2025
Via
StockStory
Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know
November 11, 2025
Via
StockStory
Topics
Artificial Intelligence
Stocks
3 Cash-Producing Stocks with Promising Prospects
November 09, 2025
Via
StockStory
This Zimmer Biomet Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
↗
November 06, 2025
Via
Benzinga
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) Presents a Compelling Value Investment Case
↗
November 05, 2025
Via
Chartmill
The 5 Most Interesting Analyst Questions From BioMarin Pharmaceutical’s Q3 Earnings Call
November 03, 2025
Via
StockStory
Topics
Earnings
Why BioMarin Pharmaceutical Stock Topped the Market on Tuesday
↗
October 28, 2025
Via
The Motley Fool
Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today
October 28, 2025
Via
StockStory
Topics
Earnings
Economy
Government
Frequently Asked Questions
Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?
Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.
What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?
BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?
The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market
What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?
The current price of BioMarin Pharmaceutical Inc. - Common Stock is 60.07
When was BioMarin Pharmaceutical Inc. - Common Stock last traded?
The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 12/24/25 11:58 AM ET
What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?
The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 11.01B
How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?
BioMarin Pharmaceutical Inc. - Common Stock has 11B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
